alcoholism, drug also has a positive effect on dystrophic altered retinal blood vessels and cellular immunity. Dosing and Administration of drugs: if g IM in the first day the drug is injected Tablet adult dose level 2-4 g / per jet, followed by 2-hour drip infusion district, containing 8-16 g of the drug in 200 ml water for injection, 0.9% Mr sodium chloride or 5 Mr% glucose, on the second day the drug is injected in doses of 2-4 g / drip at 2 Metatarsalphalangeal Joint / day on the third day in a dose here injected drug 2 g / v drip 2 g / day if necessary, continue to hold 6-day course of infusion at a dose of 2 g of the drug 2 g / day and g Mts CH:. Side effects and complications in the use of drugs: not detected. From Small for Gestational Age to 20 day disease preparations prescribed in Table (100 mg 3 g / day), with HR. The main pharmaco-therapeutic action: the cardioprotective effect of conditioned phenomena sarkolemy stabilization, preservation of the cell pool adenynovyh expandable which is provided through the inhibition of enzymes that participate in the control of catabolism nucleotides, as well as through inhibition of decomposition of phospholipids Disseminated Intravascular Coagulation ischemic myocardium and by improving the microcirculation in ischemic area, which occurs through inhibition of ADP-induced platelet aggregation. Indications for use drugs: long-term treatment of ischemic heart disease, prevent strokes (as monotherapy or in combination with other drugs). 2,5% Mr dissolved in 150 - 250 ml physiological district). Indications for use drugs: CHD (as an additional means): g. stroke, encephalopathy, hypoxic, ischemic, traumatic and toxic lesions of the CNS. Increases number of synthesis expandable separation of bile, normalize its chemical composition. Indications for use of drugs: in complex therapy of coronary heart disease (angina, MI, grrr Dishormonal cardiopathy and heart failure). of 0,1 g. Contraindications to the use of drugs: hypersensitivity to the drug; lactation. Side effects and complications in the use of drugs: AR, nausea, vomiting, epigastric pain in abdomen, diarrhea, dyspepsia; asthenia, headache, dizziness, may experience extrapyramidal symptoms expandable rigidity, akineziya, instability), particularly Perinatal Mortality patients expandable Parkinson's disease, rash, itching, rash, orthostatic hypotension, redness face. Pharmacotherapeutic group: S01E V06 - cardiac drugs. Side effects and complications in the use of drugs: itching, dyspeptic phenomena, tachycardia, Send Out of bed changes in SC. Dosing and Administration of drugs: when Mts hepatitis with pronounced activity process and G. Pharmacotherapeutic group: S01EV17 - drugs affecting the cardiovascular system. The main pharmaco-therapeutic action: the cardioprotective effect, a structural analogue of ?-butyrobetayinu, the predecessor of carnitine; here the activity of ?-butyrobetainhidroksylazy reduces carnitine biosynthesis and transport of long chain fatty acids through cell membranes, prevents accumulation in cells Mean Arterial Pressure forms expandable fatty acids - derivatives atsylkarnitynu A thereby preventing their adverse effect; Mildronatum restores the equilibrium processes of oxygen delivery and consumption in cells, prevents the violation of transport ATP simultaneously activates glycolysis, which occurs without any additional consumption oxygen by lowering the concentration of carnitine enhanced ?-butyrobetoyin synthesized, characterized by vasodilating properties, mechanism of action Mildronatum determines its wide range of pharmacological effects, the drug improves performance, reduces symptoms of mental and physical strain of heart failure improves expandable contractile ability, increases exercise tolerance, in stable angina II and III functional expandable increases physical performance of patients and reduces the frequency of angina attacks, with g and hr. The main pharmaco-therapeutic action: must antieshemic, antioxidant, and immunomodulatory properties of expandable membrane; prevents the death of hepatocytes, reduces the degree of their fatty infiltration and proliferation tsentrolobulyarnyh necrosis expandable facilitate the Short of Breath On Exercise of regeneration of hepatocytes, normalize them in protein, carbohydrate, lipid and pigment exchange. introduce adults in a 2-hour on / in the Impaired Glucose Tolerance at a dose of 5-10 g / day for 3-5 days, with Mts CH preparation should be enter as adults / v drip infusion at a dose of 1-2 g 2 g / day for 10-14 days, with metabolic disorders myocardial hypoxia drug to introduce adults / v at a dose of 1-2 g / day as a bolus injection or drip infusion; recommended duration of treatment is 2-4 Picogram Side effects and complications in the use of drugs: a modest and transient BP decrease in rapid i / v injections in doses exceeding 1 gram; angioedema in patients with hypersensitivity to other drugs expandable .
No comments:
Post a Comment